RAYMOND JAMES & ASSOCIATES, INC. | 705 | EAGLE AGGRESSIVE GROWTH PARTNERS II LP | 1415629 | 02/08/2010 | D/A | Indefinite | $9,996,433 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | Davis Investment Ventures Value Opportunity Fund I, L.P. | 1470082 | 03/26/2010 | D/A | Indefinite | $9,745,000 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | Galena Biopharma, Inc. | 1390478 | 07/26/2016 | D | $9,100,000 | $9,100,000 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | Fallbrook Technologies Inc | 1305927 | 08/18/2014 | D/A | $20,000,000 | $8,595,000 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | Carlyle Private Equity Access Blocker Fund 2014, L.P. | 1628562 | 08/25/2015 | D/A | Indefinite | $8,310,000 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | Fallbrook Technologies Inc | 1305927 | 07/14/2014 | D | $20,000,000 | $8,309,000 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | Carlyle Private Equity Access Blocker Fund 2014, L.P. | 1628562 | 07/14/2015 | D/A | Indefinite | $8,300,000 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | PLx Pharma Inc. | 1497504 | 05/29/2020 | D | $8,000,000 | $8,000,000 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | DCX Springdale DST | 1672130 | 09/14/2017 | D/A | $11,956,522 | $7,475,733 |
RAYMOND JAMES & ASSOCIATES, INC. | 705 | 2514 DIVERSIFIED LP | 1460977 | 03/16/2011 | D/A | Indefinite | $7,203,895 |